Basel, Switzerland and Budapest, Hungary, 2007/01/16
Computational solution providers Genedata and ChemAxon announce the integration of ChemAxon’s chemical visualization technology with Genedata’s lead discovery software solution. The integrated solution captures and displays discovery relevant information to help researchers identify novel drug candidates.
Scientific computing specialists at Genedata and ChemAxon have successfully integrated the chemical intelligence functionality of MarvinView with Hit Profiler, Genedata’s newly-released software solution for the prioritization of hits to leads. MarvinView is a platform-independent interactive visualization tool for viewing and managing chemical structure information.
The success of the integration rests on the fact that both companies use the same advanced software technologies, including Java 5 generics and concurrency APIs. Proven technology standards such as these have been designed and developed to make integration between systems as seamless as possible.
Seamless integration ultimately brings benefit to the scientific end-user. It means that Genedata and ChemAxon can evolve their solutions independently, yet maintain interoperability that is robust and intuitive. “Our customers recognize the value of integrated technologies for solving their business problems”, explained Dr. Stephan Heyse, Head of Genedata Screener.
Contact:
Genedata AG
Dr. Tobe Freeman
Manager Public Relations
Phone +41 61 697 8510
Fax +41 61 697 7244
Tobe.Freeman@genedata.com
www.genedata.com
ChemAxon Kft
Dr. Alex Allardyce
Director of Marketing
Phone 1-857-544-0541
www.chemaxon.com
ChemAxon is a leader in providing cheminformatics software development platforms and applications for the biotechnology, pharmaceutical and agrochemical industries. With core capabilities for structure visualization, search and management, property prediction, virtual synthesis, screening and drug design, ChemAxon focuses upon active interaction with users and software portability to create powerful, cost effective cross platform solutions and programming interfaces to power modern cheminformatics and chemical communication. For more information please visit www.chemaxon.com
Genedata specializes in discovery informatics for biotech, pharmaceuticals and the life sciences. The Company offers expertise in research informatics combined with open and scalable computational solutions. Our solutions include Genedata Phylosopher® for integrating, structuring, and analyzing research data. Genedata Screener® for high throughput screening analysis. And Genedata Expressionist® for omics data integration, processing and analysis. Founded in 1997 as a privately held spin off from Novartis, Genedata is headquartered in Basel, Switzerland and has branches in Munich (Germany), Boston (USA) and San Francisco (USA). The Company is also represented in Japan, Taiwan and Singapore. For more information about Genedata, please visit: www.genedata.com
Disclaimer
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Related Files:
PDF version